Safety and Efficacy of Aumolertinib as First-Line Treatment in EGFR-Mutant Lung Adenosquamous Carcinoma: A Multicenter, Single-Arm, Prospective Phase II Study (ARISE Study).

Ameile (aumolertinib) - Jiangsu Hansoh Pharma

http://www.ncbi.nlm.nih.gov/pubmed/42488708

Dingzhi Huang; Gen Lin; Kang Miao; Long Huang; Longfeng Zhang; Qian Chu; Qian Miao; Xiaobin Zheng; Yiquan Xu; Yongfeng Yu; Zhe Liu

Jul 24, 2026